A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
Clinical trial NCT01478594 · COMPLETED
Trial details
- NCT number
- NCT01478594
- Sponsor
- AVEO Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2013-09-01
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.